Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03958383
Title IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma
Recruitment Suspended
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Wisconsin, Madison
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.